Categories	Diseases or Functions Annotation	p-value	Molecules	# Molecules
"Cancer,Organismal Injury and Abnormalities"	Abdominal carcinoma	2.90E-07	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC1,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RFTN1,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	121
"Cancer,Organismal Injury and Abnormalities"	Nonhematologic malignant neoplasm	6.63E-07	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,C7orf65,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC1,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,HSPB2,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	129
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Skin lesion	8.30E-07	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,C7orf65,CACNA1A,CRABP1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS9,DYDC2,EBI3,EMILIN2,ERG,FBP1,FLG2,FOSB,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HSD17B6,HSPB2,IL21R,IL31RA,ISM2,ITGB2,JPH2,KCNB1,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LRRC15,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,OTOP1,PIFO,RAET1G,RASL10A,RDH16,RFTN1,RFX8,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,STOML3,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	88
"Cancer,Organismal Injury and Abnormalities"	Carcinoma	2.08E-06	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC1,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	127
"Cancer,Organismal Injury and Abnormalities"	Abdominal cancer	2.12E-06	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC1,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RDH16,RFTN1,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	122
"Cancer,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Cutaneous melanoma	2.30E-06	"ABCA4,ABCA8,ACE2,ADAMTS14,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,C7orf65,CACNA1A,CRABP1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS9,DYDC2,EMILIN2,ERG,FBP1,FLG2,FOSB,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,ISM2,ITGB2,JPH2,KCNB1,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LRRC15,MAP6,MOBP,MYH2,NMNAT2,NR4A3,OTOP1,PIFO,RASL10A,RDH16,RFTN1,RFX8,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,STOML3,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	83
"Cancer,Organismal Injury and Abnormalities"	Abdominal neoplasm	2.45E-06	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC1,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RDH16,RFTN1,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	123
"Cancer,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Skin tumor	3.12E-06	"ABCA4,ABCA8,ACE2,ADAMTS14,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,C7orf65,CACNA1A,CRABP1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS9,DYDC2,EMILIN2,ERG,FBP1,FLG2,FOSB,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HSD17B6,HSPB2,IL21R,IL31RA,ISM2,ITGB2,JPH2,KCNB1,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LRRC15,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,OTOP1,PIFO,RAET1G,RASL10A,RDH16,RFTN1,RFX8,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,STOML3,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	86
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities"	Erythrokeratodermia variabilis	7.57E-06	"GJB4,KRT83,LOR"	3
"Cancer,Organismal Injury and Abnormalities"	Extracranial solid tumor	7.92E-06	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,C7orf65,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC1,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,HSPB2,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	129
"Cancer,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Skin cancer	1.17E-05	"ABCA4,ABCA8,ACE2,ADAMTS14,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,C7orf65,CACNA1A,CRABP1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS9,DYDC2,EMILIN2,ERG,FBP1,FLG2,FOSB,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,ISM2,ITGB2,JPH2,KCNB1,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LRRC15,MAP6,MOBP,MYH2,NMNAT2,NR4A3,OTOP1,PIFO,RAET1G,RASL10A,RDH16,RFTN1,RFX8,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,STOML3,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	84
"Endocrine System Development and Function,Energy Production,Lipid Metabolism,Small Molecule Biochemistry"	Oxidation of dihydrotestosterone	1.21E-05	"DHRS9,HSD17B6,RDH16"	3
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Digestive organ tumor	1.27E-05	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,RAET1G,RAET1L,RASGRP3,RDH16,RFTN1,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,SPINK2,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	117
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Digestive system cancer	1.77E-05	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS2,DHRS9,DNAJC12,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,INPP1,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,RAET1G,RAET1L,RASGRP3,RDH16,RFTN1,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBD,UBE2QL1,ULBP2,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	115
"Cancer,Organismal Injury and Abnormalities"	Abdominal adenocarcinoma	1.86E-05	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,DYDC1,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NMNAT2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RFTN1,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	112
"Humoral Immune Response,Protein Synthesis"	Production of antibody	3.54E-05	"CTSS,DAPP1,IL21R,IL31RA,ITGB2,PDCD1LG2,PLP1,RASGRP3,RFTN1,TNFRSF9,VIPR2"	11
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Quantity of 11-cis-retinol	3.67E-05	"ABCA4,RDH16"	2
Cellular Development	Epithelial to mesenchymal transdifferentiation of pancreatic cancer cell lines	3.67E-05	"AZGP1,MUC1"	2
"Cancer,Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Growth of pancreatic carcinoma	6.02E-05	"CTSS,FBLN5,MUC1"	3
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Quantity of retinoid	6.64E-05	"ABCA4,CRABP1,OLR1,RDH16"	4
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Large intestine carcinoma	7.04E-05	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	99
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Large intestine adenocarcinoma	9.59E-05	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	98
"Cancer,Organismal Injury and Abnormalities"	Pelvic cancer	1.01E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DHRS9,DYDC1,EMILIN2,ERG,FBLN5,FLG2,FOSB,GBX1,GFRA3,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,ITGB2,IZUMO4,JPH2,KCNB1,KCNK9,KRT23,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RTP4,RXRG,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	82
"Humoral Immune Response,Protein Synthesis"	Quantity of immunoglobulin	1.04E-04	"CTSS,DAPP1,IL21R,IL31RA,ITGB2,PDCD1LG2,RASGRP3,RFTN1,TNFRSF9,VIPR2"	10
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities"	Progressive symmetric erythrokeratoderma	1.10E-04	"GJB4,KRT83"	2
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Female genital tract serous carcinoma	1.17E-04	"ABCA8,CACNA1A,CRABP1,DAB2,ERG,FBLN5,HSD17B6,KCNB1,MUC1,PLP1,RAET1G,SAA1"	12
"Gastrointestinal Disease,Organismal Injury and Abnormalities"	Oral submucous fibrosis	1.61E-04	"LOR,LRRC15,MYH2,UBD"	4
"Cancer,Organismal Injury and Abnormalities"	Cancer of secretory structure	1.74E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAPP1,DDIT4,DHRS2,DHRS9,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,GBX1,GFRA3,GGTLC2,GPD1,GRPR,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,LY96,MAB21L4,MAP6,MOBP,MUC1,MYH2,NR4A3,ODAPH,OLR1,OPN1SW,OTOP1,PDCD1LG2,PRR9,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RTP4,RXRG,RYR3,SAA1,SCEL,SCIN,SH2D1B,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TP53I3,TSPAN11,UBE2QL1,ULBP2,VIPR2,VTN,VWA5B1,WSCD2,ZMYND15"	108
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Gastrointestinal adenocarcinoma	1.80E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	99
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Response of lymphocytes	1.96E-04	"CTSS,DAPP1,EBI3,IL21R,PDCD1LG2,PLP1,TNFRSF9,VTN"	8
"Cancer,Inflammatory Response,Organismal Injury and Abnormalities,Tumor Morphology"	Rejection of tumor	1.99E-04	"IL21R,PDCD1LG2,TNFRSF9"	3
"Cancer,Organismal Injury and Abnormalities"	Melanoma	2.01E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,C7orf65,CACNA1A,CRABP1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS9,DYDC2,EMILIN2,ERG,FBLN5,FBP1,FLG2,FOSB,GFRA3,GGTLC2,GJB4,GPD1,GRPR,HHLA2,HSD17B6,HSPB2,IL21R,IL31RA,ISM2,ITGB2,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LRRC15,MAP6,MOBP,MYH2,NMNAT2,NR4A3,OTOP1,PIFO,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RXRG,RYR3,SAA1,SCEL,SCIN,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,STOML3,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZBED2,ZMYND15"	87
"Cell-To-Cell Signaling and Interaction,Hair and Skin Development and Function"	Adhesion of epithelial cell lines	2.07E-04	"DAB2,ITGB2,MUC1,VTN"	4
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Uterine serous papillary cancer	2.41E-04	"ABCA8,CRABP1,ERG,FBLN5,HSD17B6,KCNB1,PLP1,SAA1"	8
"Humoral Immune Response,Protein Synthesis"	Quantity of IgG	2.73E-04	"CTSS,DAPP1,IL21R,ITGB2,PDCD1LG2,RASGRP3,RFTN1,TNFRSF9"	8
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Gastrointestinal carcinoma	2.78E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	101
Cell Morphology	Keratinization	2.89E-04	"KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LOR,SPINK6,TGM1"	7
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Large intestine neoplasm	3.05E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	101
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Concentration of retinol	3.12E-04	"ABCA4,OLR1,RDH16"	3
"Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response"	Efferocytosis of neutrophils	3.63E-04	"SAA1,VTN"	2
Behavior	Sighing	3.63E-04	"CACNA1A,GRPR"	2
"Humoral Immune Response,Protein Synthesis"	Quantity of IgM	3.65E-04	"CTSS,DAPP1,IL21R,ITGB2,PDCD1LG2,TNFRSF9"	6
"Cancer,Organismal Injury and Abnormalities"	Malignant genitourinary solid tumor	3.68E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DHRS9,DYDC1,EMILIN2,ERG,FBLN5,FLG2,FOSB,GBX1,GFRA3,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,ITGB2,IZUMO4,JPH2,KCNB1,KCNK9,KLHL6,KRT23,LOR,LRRC15,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RTP4,RXRG,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STOML3,STX11,SYT17,SYTL2,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	88
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Metabolism of retinoid	4.39E-04	"ABCA4,CYP2J2,DHRS9,OPN1SW,RDH16"	5
Cell-To-Cell Signaling and Interaction	Attachment of cells	4.62E-04	"ACE2,DAB2,FBLN5,ITGB2,OLR1,VTN"	6
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Malignant neoplasm of large intestine	4.88E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	100
Cell-To-Cell Signaling and Interaction	Attachment of blood cells	5.17E-04	"ACE2,ITGB2,OLR1"	3
Cellular Function and Maintenance	Function of blood cells	5.44E-04	"BIRC3,CTSS,EBI3,ERG,IL21R,IL31RA,ITGB2,LY96,PDCD1LG2,SH2D1B,STX11,TNFRSF9,UBD"	13
Cellular Function and Maintenance	Function of leukocytes	6.64E-04	"BIRC3,CTSS,EBI3,IL21R,IL31RA,ITGB2,LY96,PDCD1LG2,SH2D1B,STX11,TNFRSF9,UBD"	12
"Cellular Function and Maintenance,Hematological System Development and Function"	Function of lymphocytes	6.76E-04	"BIRC3,CTSS,EBI3,IL21R,PDCD1LG2,SH2D1B,STX11,TNFRSF9,UBD"	9
"Cancer,Organismal Injury and Abnormalities"	Anogenital cancer	6.81E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DHRS9,DYDC1,EMILIN2,ERG,FBLN5,FLG2,FOSB,GBX1,GFRA3,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,IZUMO4,JPH2,KCNB1,KCNK9,KLHL6,KRT23,LRRC15,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OTOP1,PDCD1LG2,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RTP4,RXRG,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,SPINK2,STOML3,SYT17,SYTL2,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	82
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Genital tract cancer	6.84E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ASB2,ATP13A4,ATP6V0A4,AZGP1,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DHRS9,DYDC1,ERG,FBLN5,FLG2,GBX1,GFRA3,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,IZUMO4,JPH2,KCNB1,KCNK9,KRT23,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OTOP1,PDCD1LG2,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RTP4,RXRG,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,SYT17,SYTL2,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	75
"Humoral Immune Response,Protein Synthesis"	Quantity of IgG2a	6.95E-04	"IL21R,PDCD1LG2,RASGRP3,RFTN1,TNFRSF9"	5
"Hematological System Development and Function,Humoral Immune Response,Immune Cell Trafficking,Inflammatory Response,Tissue Development"	Accumulation of plasma cells	7.56E-04	"IL21R,ITGB2"	2
"Cellular Compromise,Inflammatory Response"	Degranulation of natural killer cells	7.93E-04	"RAET1G,STX11,ULBP2"	3
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Activation of mononuclear leukocytes	8.20E-04	"DAPP1,IL21R,ITGB2,LY96,NR4A3,PDCD1LG2,PLP1,SAA1,STX11,TNFRSF9,ULBP2,VIPR2"	12
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities"	Genodermatosis	8.80E-04	"CACNA1A,GJB4,KRT83,LOR"	4
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Gastrointestinal tumor	8.88E-04	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	103
"Cancer,Organismal Injury and Abnormalities"	Serous adenocarcinoma	9.25E-04	"ABCA8,ASB2,AZGP1,CACNA1A,CRABP1,CRTAC1,DAB2,ERG,FBLN5,HHLA2,HSD17B6,KCNB1,MUC1,PLP1,RAET1G,RYR3,SAA1,TNFRSF9"	18
"Organismal Injury and Abnormalities,Respiratory Disease"	Lung injury	9.26E-04	"AZGP1,DDIT4,IL21R,ITGB2,LY96,MUC1,OLR1"	7
"Endocrine System Disorders,Organismal Injury and Abnormalities,Reproductive System Disease"	Aspermatogenesis	1.05E-03	"TEX14,TEX15,ZMYND15"	3
"Cell Morphology,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Cell spreading of phagocytes	1.25E-03	"ASB2,ITGB2,VTN"	3
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Genital tumor	1.27E-03	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ASB2,ATP13A4,ATP6V0A4,AZGP1,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DHRS9,DYDC1,ERG,FBLN5,FLG2,GBX1,GFRA3,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,IZUMO4,JPH2,KCNB1,KCNK9,KRT23,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OTOP1,PDCD1LG2,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RTP4,RXRG,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,SYT17,SYTL2,TEX14,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	75
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Gastrointestinal tract cancer	1.33E-03	"ABCA4,ABCA8,ACE2,ADAMTS14,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CEND1,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DDIT4,DHRS9,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,FOSB,GBX1,GFRA3,GJB4,GPD1,GRPR,HHLA2,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KCNK9,KLHL6,KRT23,KRT83,LCE1E,LCE1F,LIPH,LOR,LRRC15,LY96,MAB21L4,MAP6,MUC1,MYH2,NR4A3,OLR1,OPN1SW,OTOP1,PDCD1LG2,PIFO,PLP1,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SCEL,SCIN,SIRPB2,SLC18A3,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TENT5C,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TSPAN11,UBD,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	102
Infectious Diseases	Infection of mammalia	1.33E-03	"EBI3,IL21R,IL31RA,ITGB2,LY96,PDCD1LG2,STX11,TNFRSF9,UBD"	9
Lymphoid Tissue Structure and Development	Frequency of lymphocytes	1.38E-03	"EBI3,IL21R,PDCD1LG2,RASGRP3,TNFRSF9"	5
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Immune response of leukocytes	1.54E-03	"CTSS,ITGB2,LY96,MUC1,PDCD1LG2,PLP1,SAA1,TNFRSF9,VTN"	9
"Cancer,Organismal Injury and Abnormalities"	Genitourinary carcinoma	1.55E-03	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ASB2,ATP13A4,ATP6V0A4,AZGP1,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DHRS9,DYDC1,EMILIN2,ERG,FBLN5,FLG2,FOSB,GBX1,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,ITGB2,IZUMO4,JPH2,KCNB1,KCNK9,LRRC15,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OPN1SW,OTOP1,PIFO,PLP1,PRR9,RAET1G,RAET1L,RASGRP3,RTP4,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,STX11,SYT17,SYTL2,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	77
"Cellular Function and Maintenance,Hematological System Development and Function"	Function of memory T lymphocytes	1.60E-03	"IL21R,TNFRSF9"	2
"Cellular Compromise,Inflammatory Response"	Degranulation of T lymphocytes	1.60E-03	"STX11,TNFRSF9"	2
"Drug Metabolism,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Synthesis of alitretinoin	1.60E-03	"DHRS9,RDH16"	2
"Endocrine System Development and Function,Lipid Metabolism,Small Molecule Biochemistry"	Conversion of dihydrotestosterone	1.60E-03	"HSD17B6,RDH16"	2
Carbohydrate Metabolism	Activation of polysaccharide	1.60E-03	"LY96,VTN"	2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Activation of lymphocytes	1.80E-03	"DAPP1,IL21R,ITGB2,NR4A3,PDCD1LG2,PLP1,SAA1,STX11,TNFRSF9,ULBP2,VIPR2"	11
"Cancer,Organismal Injury and Abnormalities"	Genitourinary adenocarcinoma	1.85E-03	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ASB2,ATP13A4,ATP6V0A4,AZGP1,C1QTNF2,CACNA1A,CRABP1,CRTAC1,DAB2,DDIT4,DHRS9,DYDC1,ERG,FBLN5,FLG2,GBX1,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,IZUMO4,JPH2,KCNB1,KCNK9,LRRC15,LY96,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OLR1,OPN1SW,OTOP1,PLP1,PRR9,RAET1G,RASGRP3,RTP4,RYR3,SAA1,SCIN,SH2D1B,SIRPB2,SLC18A3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,SYT17,SYTL2,TEX15,TGM1,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,UBE2QL1,VIPR2,VSIG1,VTN,VWA5B1,WSCD2,ZMYND15"	70
"Hematological Disease,Metabolic Disease,Organismal Injury and Abnormalities"	Dyslipidemia	1.87E-03	"ABCA8,CTSS,DAB2,GPD1,NR4A3,RXRG"	6
Immunological Disease	Delayed hypersensitive reaction	1.89E-03	"IL21R,ITGB2,PLP1,TNFRSF9,VIPR2"	5
Molecular Transport	Transport of ion	1.90E-03	"ATP13A4,ATP6V0A4,CA13,CACNA1A,KCNB1,KCNG3,KCNK9,OTOP1,RYR3,SLC18A3,STOML3,SYTL2"	12
"Organismal Injury and Abnormalities,Respiratory Disease"	Edema of lung	2.06E-03	"CA13,ERG,OLR1,VTN"	4
"Lymphoid Tissue Structure and Development,Tissue Morphology"	Quantity of lymphatic system cells	2.13E-03	"CTSS,DAPP1,EBI3,FOSB,IL21R,IL31RA,ITGB2,KLHL6,MUC1,PDCD1LG2,PLP1,RASGRP3,RFTN1,SAA1,TNFRSF9,VIPR2"	16
"Hematological System Development and Function,Tissue Morphology"	Quantity of leukocytes	2.28E-03	"BIRC3,CACNA1A,CTSS,DAPP1,EBI3,FOSB,IL21R,ITGB2,KLHL6,MUC1,PDCD1LG2,PLP1,RASGRP3,SAA1,STX11,TNFRSF9,VIPR2,VTN"	18
"Cell-mediated Immune Response,Lymphoid Tissue Structure and Development"	Frequency of T lymphocytes	2.33E-03	"EBI3,IL21R,RASGRP3,TNFRSF9"	4
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Quantity of retinyl ester	2.33E-03	"ABCA4,RDH16"	2
"Cell Death and Survival,Skeletal and Muscular Disorders"	Cell death of myofiber	2.33E-03	"CTSS,SLC18A3"	2
"Cell-mediated Immune Response,Lymphoid Tissue Structure and Development"	Frequency of CD8+ T lymphocyte	2.33E-03	"IL21R,TNFRSF9"	2
Cell-To-Cell Signaling and Interaction	Binding of bacteria	2.43E-03	"ITGB2,MUC1,VTN"	3
"Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities"	Diabetes mellitus	2.51E-03	"ACE2,ARHGDIG,ASB2,AZGP1,CA13,CACNA1A,CTSS,FBP1,GPR1,HCP5,IL21R,ITGB2,MOBP,NR4A3,OLR1,OPN1SW,PDCD1LG2,RDH16,RTP4,RYR3,SH2D1B,TNFRSF9"	22
Cell-To-Cell Signaling and Interaction	Attachment of myeloid cells	2.74E-03	"ITGB2,OLR1"	2
"Cancer,Organismal Injury and Abnormalities"	Neoplasia of cells	2.84E-03	"ABCA4,ADAMTS14,ARHGDIG,ART5,ATP13A4,ATP6V0A4,BIRC3,C1QTNF2,CACNA1A,CRTAC1,DAAM1,DAB2,DNAJC12,EBI3,EMILIN2,ERG,FBLN5,FBP1,FLG2,GBX1,GJB4,GRPR,HHLA2,HOXD1,HSD17B6,IL21R,IL31RA,ITGB2,IZUMO4,JPH2,KCNK9,KLHL6,KRT23,KRTAP2-3/KRTAP2-4,LCE1F,LOR,MAB21L4,MUC1,MYH2,NR4A3,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SLC7A7,SLCO5A1,SMPDL3B,STOML3,STX11,SYTL2,TENT5C,TEX14,TEX15,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,UBE2QL1,VSIG1,VTN"	65
Cell Death and Survival	Cytolysis of leukocytes	2.93E-03	"IL21R,ITGB2,SH2D1B,STX11"	4
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Activation of leukocytes	3.11E-03	"CTSS,DAPP1,IL21R,ITGB2,LY96,NR4A3,PDCD1LG2,PLP1,SAA1,STX11,TNFRSF9,ULBP2,VIPR2,VTN"	14
"Cell-To-Cell Signaling and Interaction,Cellular Compromise,Cellular Function and Maintenance,Inflammatory Response"	Respiratory burst of phagocytes	3.12E-03	"ITGB2,TNFRSF9,VTN"	3
"Endocrine System Disorders,Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities"	Insulitis	3.12E-03	"CTSS,ITGB2,PDCD1LG2"	3
"Drug Metabolism,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Synthesis of tretinoin	3.19E-03	"DHRS9,RDH16"	2
"Drug Metabolism,Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Concentration of tretinoin	3.19E-03	"CRABP1,OLR1"	2
Molecular Transport	Transmembrane transport of ion	3.24E-03	"ATP13A4,ATP6V0A4,OTOP1,RYR3,STOML3"	5
"Cellular Function and Maintenance,Hematological System Development and Function"	Function of T lymphocytes	3.62E-03	"BIRC3,CTSS,EBI3,IL21R,PDCD1LG2,STX11,TNFRSF9"	7
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking"	Attachment of phagocytes	3.66E-03	"ITGB2,OLR1"	2
Cell Morphology	Shape change of antigen presenting cells	3.66E-03	"ASB2,VTN"	2
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Respiratory burst of myeloid cells	4.13E-03	"ITGB2,TNFRSF9,VTN"	3
"Hematological System Development and Function,Tissue Morphology"	Quantity of myeloid cells	4.22E-03	"BIRC3,CACNA1A,CTSS,EBI3,IL21R,ITGB2,PLP1,STX11,TNFRSF9,VIPR2,VTN"	11
"Dermatological Diseases and Conditions,Developmental Disorder,Organismal Injury and Abnormalities"	Congenital anomaly of skin	4.28E-03	"CACNA1A,FBLN5,GJB4,KRT83,LOR"	5
Molecular Transport	Transport of cation	4.38E-03	"ATP6V0A4,CACNA1A,KCNB1,KCNG3,KCNK9,OTOP1,RYR3,SLC18A3,SYTL2"	9
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Immune response of antigen presenting cells	4.49E-03	"CTSS,ITGB2,LY96,MUC1,SAA1,VTN"	6
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Response of helper T lymphocytes	4.59E-03	"IL21R,PDCD1LG2,PLP1"	3
Cellular Compromise	Stress response of kidney cell lines	4.71E-03	"HSPB2,OPN1SW"	2
Hematological Disease	Pancytopenia	4.71E-03	"ERG,STX11"	2
"Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease"	Early stage diabetic nephropathy	4.71E-03	"ACE2,CA13"	2
"Cancer,Organismal Injury and Abnormalities"	Neck neoplasm	5.16E-03	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,GBX1,GFRA3,GGTLC2,GPD1,GRPR,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,MAB21L4,MAP6,MOBP,MUC1,MYH2,NR4A3,OPN1SW,OTOP1,PDCD1LG2,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RYR3,SCEL,SCIN,SH2D1B,SLCO5A1,SMPDL3B,SPINK2,STX11,SYT17,SYTL2,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBE2QL1,ULBP2,VIPR2,VTN,VWA5B1,WSCD2,ZMYND15"	95
Inflammatory Response	Cell-mediated response	5.22E-03	"EBI3,MUC1,PDCD1LG2,SH2D1B,STX11,TNFRSF9"	6
"Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development"	Proliferative capacity of regulatory T lymphocytes	5.32E-03	"IL21R,PLP1,TNFRSF9"	3
Cell Death and Survival	Cytolysis of natural killer cells	5.58E-03	"IL21R,SH2D1B,STX11"	3
"Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Autosomal dominant maculopathy	5.87E-03	"ABCA4,FBLN5"	2
"Cell Death and Survival,Organismal Injury and Abnormalities"	Anoikis of epithelial cell lines	5.87E-03	"BIRC3,VTN"	2
"Cardiovascular Disease,Organismal Injury and Abnormalities"	Binding of blood clot	6.08E-03	VTN	1
"Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities"	Autosomal recessive familial hemophagocytic lymphohistiocytosis type 4	6.08E-03	STX11	1
"Cell Morphology,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Cell spreading of bone marrow-derived macrophages	6.08E-03	VTN	1
"Cellular Compromise,Cellular Function and Maintenance,Organismal Injury and Abnormalities"	Endoplasmic reticulum stress response of retinal rods	6.08E-03	OPN1SW	1
Cell Death and Survival	Cell viability of bronchial epithelial cells	6.08E-03	UBD	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry"	"Epoxidation of 11,12-epoxyeicosatrienoic acid"	6.08E-03	CYP2J2	1
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Immune response of myeloma cell lines	6.08E-03	PDCD1LG2	1
Cell-To-Cell Signaling and Interaction	Attachment of blood platelets	6.08E-03	ACE2	1
"Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization,Skeletal and Muscular System Development and Function"	Delay in initiation of fusion of muscle cell lines	6.08E-03	ASB2	1
Inflammatory Response	Pus	6.08E-03	ITGB2	1
"Hereditary Disorder,Organismal Injury and Abnormalities"	ABCA4-related disorder	6.08E-03	ABCA4	1
"Connective Tissue Development and Function,Reproductive System Development and Function"	Decidualization of endometrial stromal cells	6.08E-03	TGM1	1
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Interaction of neutrophils	6.08E-03	SAA1	1
"Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities"	IL21R immunodeficiency	6.08E-03	IL21R	1
"Cell-To-Cell Signaling and Interaction,Nervous System Development and Function"	Miniature end-plate potential of neuromuscular junctions	6.08E-03	SLC18A3	1
"Cellular Development,Tissue Development"	Differentiation of epithelial stem cells	6.08E-03	IHH	1
"Cancer,Dermatological Diseases and Conditions,Developmental Disorder,Hematological Disease,Hereditary Disorder,Immunological Disease,Metabolic Disease,Organismal Injury and Abnormalities"	Primary localized cutaneous amyloidosis type 2	6.08E-03	IL31RA	1
Cellular Assembly and Organization	Quantity of mucigen granules	6.08E-03	SYTL2	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry"	"Epoxidation of 8,9-epoxyeicosatrienoic acid"	6.08E-03	CYP2J2	1
Cellular Function and Maintenance	Elimination of colorectal cancer cell lines	6.08E-03	RXRG	1
"Connective Tissue Disorders,Developmental Disorder,Organismal Injury and Abnormalities"	Elastinopathy	6.08E-03	FBLN5	1
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Cytotoxic T lymphocyte response by monocyte-derived dendritic cells	6.08E-03	MUC1	1
Cell Morphology	Elongation of chondrocytes	6.08E-03	IHH	1
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Conversion of 9-cis-retinal	6.08E-03	RDH16	1
"Carbohydrate Metabolism,Energy Production,Small Molecule Biochemistry"	Oxidation of 2-deoxyglucose	6.08E-03	AZGP1	1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Autosomal recessive acrocapitofemoral dysplasia	6.08E-03	IHH	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Episodic ataxia type 2 and epilepsy	6.08E-03	CACNA1A	1
"Cardiovascular System Development and Function,Embryonic Development,Organismal Development,Tissue Development"	Vasculogenesis of epiblast	6.08E-03	IHH	1
"Cell Morphology,Organ Morphology,Skeletal and Muscular System Development and Function,Tissue Morphology"	Morphology of fast twitch oxidative muscle fibers	6.08E-03	MYH2	1
"Connective Tissue Disorders,Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities"	Autosomal dominant cutis laxa type 2	6.08E-03	FBLN5	1
"Cancer,Cellular Development,Cellular Growth and Proliferation,Hematological Disease,Organismal Injury and Abnormalities,Tumor Morphology"	Arrest in growth of acute myeloid leukemia blast cells	6.08E-03	MUC1	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Sporadic hemiplegic migraine with progressive cerebellar ataxia	6.08E-03	CACNA1A	1
"Cell Morphology,Tissue Morphology"	Volume of leukemia cell lines	6.08E-03	SCIN	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Translocation of galactosylceramide	6.08E-03	PLP1	1
Neurological Disease	Chronic progressive ataxia	6.08E-03	CACNA1A	1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities"	"Fructose-1,6-diphosphatase deficiency"	6.08E-03	FBP1	1
"Connective Tissue Development and Function,Organismal Development,Skeletal and Muscular System Development and Function,Tissue Morphology"	Mass of femoral subcutaneous fat	6.08E-03	RDH16	1
Cell Death and Survival	Killing of Yersinia pestis	6.08E-03	LY96	1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease"	Lysinuric protein intolerance	6.08E-03	SLC7A7	1
Cell Cycle	Endomitosis of monocytes	6.08E-03	TNFRSF9	1
"Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Susceptibility to age-related macular degeneration type 2	6.08E-03	ABCA4	1
"Cellular Development,Digestive System Development and Function,Tissue Development"	Differentiation of colonocytes	6.08E-03	IHH	1
"Hereditary Disorder,Neurological Disease,Ophthalmic Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Proximal myopathy and ophthalmoplegia	6.08E-03	MYH2	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Translocation of glucosylceramide	6.08E-03	PLP1	1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities"	Erythrokeratodermia variabilis et progressiva 2	6.08E-03	GJB4	1
"Embryonic Development,Hematological System Development and Function,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development"	Formation of thymus medulla	6.08E-03	FOSB	1
"Organismal Development,Visual System Development and Function"	Delay in dark adaptation of mice	6.08E-03	ABCA4	1
Cellular Growth and Proliferation	Clonogenicity of fibrosarcoma cell lines	6.08E-03	EMILIN2	1
"Cellular Movement,Nervous System Development and Function"	Migration of superior cervical ganglion neurons	6.08E-03	GFRA3	1
"Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Retinitis pigmentosa type 19	6.08E-03	ABCA4	1
"Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities"	Autosomal recessive leukocyte adhesion deficiency	6.08E-03	ITGB2	1
"Cellular Movement,Embryonic Development"	Distribution of mesodermal cells	6.08E-03	NR4A3	1
Cell Death and Survival	Cytolysis of neutrophils	6.08E-03	ITGB2	1
"Embryonic Development,Tissue Development"	Accumulation of mesoderm	6.08E-03	NR4A3	1
"Cell Morphology,Cellular Assembly and Organization,Nervous System Development and Function"	Structure of myelin sheath	6.08E-03	PLP1	1
Cellular Growth and Proliferation	Inhibition of Salmonella	6.08E-03	UBD	1
"Carbohydrate Metabolism,Lipid Metabolism,Small Molecule Biochemistry"	"Recruitment of phosphatidylinositol 4,5-diphosphate"	6.08E-03	VTN	1
"Embryonic Development,Organ Development,Organismal Development,Reproductive System Development and Function,Tissue Development"	Development of ampulla of seminal vesicle	6.08E-03	NR4A3	1
"Cell Morphology,Cellular Function and Maintenance"	Autophagy of thymoma cell lines	6.08E-03	DDIT4	1
"Ophthalmic Disease,Organismal Injury and Abnormalities"	Age-related macular degeneration type 3	6.08E-03	FBLN5	1
"Organ Morphology,Renal and Urological System Development and Function"	Quantity of mesangial matrix	6.08E-03	ACE2	1
"Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Organismal Development,Tissue Development"	Hematopoiesis of epiblast cells	6.08E-03	IHH	1
Tissue Development	Organization of elastic fibers	6.08E-03	FBLN5	1
Cellular Function and Maintenance	Maintenance of blood platelets	6.08E-03	ERG	1
"Embryonic Development,Hematological System Development and Function,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development"	Formation of thymus cortex	6.08E-03	FOSB	1
Neurological Disease	Degeneration of superior cervical ganglion	6.08E-03	GFRA3	1
"Endocrine System Disorders,Hereditary Disorder,Organismal Injury and Abnormalities,Reproductive System Disease"	Spermatogenic failure 25	6.08E-03	TEX15	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Familial hemiplegic migraine type 1 with progressive cerebellar ataxia	6.08E-03	CACNA1A	1
"Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Tritan colorblindness	6.08E-03	OPN1SW	1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Immunological Disease,Inflammatory Disease,Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities,Renal and Urological Disease"	Medullary cystic kidney disease 1	6.08E-03	MUC1	1
Cell-To-Cell Signaling and Interaction	Binding of Helicobacter pylori	6.08E-03	VTN	1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Early infantile epileptic encephalopathy 42	6.08E-03	CACNA1A	1
"Cell Morphology,Hematological System Development and Function,Hematopoiesis"	Polarization of lymphoblasts	6.08E-03	ITGB2	1
"Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities"	Elevated level of IgE	6.08E-03	IL21R	1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities"	Erythrokeratodermia variabilis et progressiva 5	6.08E-03	KRT83	1
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Conversion of 9-cis-retinol	6.08E-03	RDH16	1
"Cellular Movement,Embryonic Development"	Positioning of endodermal cells	6.08E-03	DAB2	1
Hematological System Development and Function	Binding of serum	6.08E-03	VTN	1
"Endocrine System Disorders,Hereditary Disorder,Organismal Injury and Abnormalities,Reproductive System Disease"	Spermatogenic failure 23	6.08E-03	TEX14	1
"Cardiovascular Disease,Hematological Disease,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities"	Transient infantile hypertriglyceridemia	6.08E-03	GPD1	1
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Generation of vitamin A	6.08E-03	ABCA4	1
"Amino Acid Metabolism,Post-Translational Modification,Small Molecule Biochemistry"	Deamidation of glutamine	6.08E-03	TGM1	1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Cone-rod dystrophy type 3	6.08E-03	ABCA4	1
"Carbohydrate Metabolism,Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Quantity of N-retinylidene-phosphatidylethanolamine	6.08E-03	ABCA4	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry"	Epoxidation of arachidonic acid	6.08E-03	CYP2J2	1
"Cellular Movement,Endocrine System Development and Function"	Migration of beta islet cells	6.08E-03	VTN	1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Organismal Injury and Abnormalities,Reproductive System Disease"	X-linked congenital bilateral aplasia of vas deferens	6.08E-03	ADGRG2	1
"Dermatological Diseases and Conditions,Hereditary Disorder,Organismal Injury and Abnormalities"	Loricrin keratoderma	6.08E-03	LOR	1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders,Skeletal and Muscular Disorders"	Connatal Pelizaeus-Merzbacher disease	6.08E-03	PLP1	1
"Cell Morphology,Cellular Movement,Nervous System Development and Function"	Innervation of superior cervical ganglion neurons	6.08E-03	GFRA3	1
Cell Death and Survival	Killing of B lymphoblastoid cell lines	6.08E-03	RAET1L	1
Cellular Compromise	Degeneration of keratohyalin granules	6.08E-03	TGM1	1
"Cellular Assembly and Organization,Skeletal and Muscular System Development and Function"	Binding of sarcoplasmic reticulum	6.08E-03	CACNA1A	1
Post-Translational Modification	Esterification of protein	6.08E-03	TGM1	1
"Dental Disease,Developmental Disorder,Gastrointestinal Disease,Hereditary Disorder,Organismal Injury and Abnormalities"	Hypomaturation type amelogenesis imperfecta type IIA4	6.08E-03	ODAPH	1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Early infantile epileptic encephalopathy type 26	6.08E-03	KCNB1	1
"Developmental Disorder,Neurological Disease,Skeletal and Muscular Disorders"	Birk-Barel syndrome	6.08E-03	KCNK9	1
"Cell Death and Survival,Visual System Development and Function"	Delay in recovery of retinal rods	6.08E-03	ABCA4	1
"Cell Morphology,Cellular Function and Maintenance"	Autophagy of thymocytes	6.08E-03	DDIT4	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Autosomal dominant episodic ataxia type 2	6.08E-03	CACNA1A	1
"Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities"	Persistent neutrophilia	6.08E-03	ITGB2	1
Nervous System Development and Function	Development of superior cervical ganglion	6.08E-03	GFRA3	1
Hair and Skin Development and Function	Stabilization of stratum corneum	6.08E-03	LOR	1
"Carbohydrate Metabolism,Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Transport of N-retinylidene-phosphatidylethanolamine	6.08E-03	ABCA4	1
"Lipid Metabolism,Small Molecule Biochemistry"	Upregulation of ceramide	6.08E-03	DDIT4	1
"Cardiovascular System Development and Function,Cell Death and Survival"	Survival of endothelial progenitor cells	6.08E-03	OLR1	1
Cellular Assembly and Organization	Stabilization of sarcolemma	6.08E-03	CTSS	1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders,Skeletal and Muscular Disorders"	Atypical Pelizaeus-Merzbacher disease	6.08E-03	PLP1	1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities"	Non-BH4-deficient mild hyperphenylalaninemia	6.08E-03	DNAJC12	1
Skeletal and Muscular System Development and Function	Progression of subperiosteal bony collar	6.08E-03	IHH	1
"Dermatological Diseases and Conditions,Hereditary Disorder,Organismal Injury and Abnormalities"	Autosomal recessive woolly hair 2	6.08E-03	LIPH	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Oxidation of 13-cis-retinal	6.08E-03	RDH16	1
"Cellular Compromise,Inflammatory Response"	Degranulation of CD8+ T lymphocyte	6.08E-03	TNFRSF9	1
"Cardiovascular Disease,Cardiovascular System Development and Function,Hereditary Disorder,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	ANKRD1-related dilated cardiomyopathy	6.08E-03	ANKRD1	1
Cellular Assembly and Organization	Leakage of phosphatidylcholine-phosphatidylserine large unilamellar vesicle	6.08E-03	VTN	1
Cellular Function and Maintenance	Turnover of myofiber	6.08E-03	CTSS	1
"Developmental Disorder,Hereditary Disorder,Immunological Disease,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Presynaptic congenital myasthenic syndrome type 21	6.08E-03	SLC18A3	1
"Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Organismal Development,Tissue Development"	Growth of mesodermal cells	6.08E-03	NR4A3	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Translocation of lactosylceramide	6.08E-03	PLP1	1
"Nervous System Development and Function,Visual System Development and Function"	Delay in initiation of dark adaptation of eye	6.08E-03	ABCA4	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Concentration of 11-cis-retinal	6.08E-03	ABCA4	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Hereditary spastic paraplegia X-linked	6.08E-03	PLP1	1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Organismal Injury and Abnormalities,Reproductive System Disease"	Spermatogenic failure 14	6.08E-03	ZMYND15	1
"Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Tissue Development"	Megakaryopoiesis of hematopoietic progenitor cells	6.08E-03	ERG	1
"Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development"	Clonal expansion of Th2 cells	6.08E-03	PLP1	1
Cell Morphology	Architecture of filopodia	6.08E-03	DAAM1	1
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Familial hypertrophic cardiomyopathy type 17	6.08E-03	JPH2	1
"Behavior,Organismal Functions"	Walking	6.13E-03	"CACNA1A,CEND1,GBX1"	3
Tissue Morphology	Quantity of cells	6.21E-03	"ABCA4,BIRC3,CACNA1A,CTSS,CYP2J2,DAPP1,EBI3,FOSB,GBX1,IHH,IL21R,IL31RA,ITGB2,KLHL6,MAP6,MUC1,NR4A3,PDCD1LG2,PLP1,RASGRP3,RFTN1,SAA1,SLC18A3,STX11,SYTL2,TNFRSF9,VIPR2,VTN"	28
"Cellular Growth and Proliferation,Lymphoid Tissue Structure and Development"	Proliferation of lymphatic system cells	6.39E-03	"BIRC3,DAPP1,EBI3,ERG,HHLA2,IL21R,IL31RA,ITGB2,LY96,NR4A3,PDCD1LG2,PLP1,RASGRP3,TNFRSF9,ULBP2"	15
"Cardiovascular System Development and Function,Cell-To-Cell Signaling and Interaction"	Attachment of endothelial cells	6.50E-03	"FBLN5,ITGB2"	2
"Cell Cycle,Inflammatory Response"	Effector phase	6.50E-03	"PDCD1LG2,TNFRSF9"	2
"Endocrine System Development and Function,Small Molecule Biochemistry"	Metabolism of androgen	6.50E-03	"DHRS9,HSD17B6"	2
"Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology"	Quantity of lymphocytes	6.50E-03	"CTSS,DAPP1,EBI3,FOSB,IL21R,ITGB2,KLHL6,MUC1,PDCD1LG2,PLP1,RASGRP3,SAA1,TNFRSF9,VIPR2"	14
"Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response"	Phagocytosis of neutrophils	7.00E-03	"ITGB2,SAA1,VTN"	3
"Cellular Growth and Proliferation,Connective Tissue Development and Function,Tissue Development"	Proliferation of fibroblast-like synoviocytes	7.15E-03	"SAA1,VTN"	2
Cardiovascular Disease	Childhood hypertension	7.15E-03	"ACE2,CA13"	2
Molecular Transport	Transport of inorganic cation	7.31E-03	"ATP6V0A4,CACNA1A,KCNB1,KCNG3,KCNK9,OTOP1,RYR3,SYTL2"	8
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry"	Oxidation of lipid	7.54E-03	"C1QTNF2,CYP2J2,DHRS9,HSD17B6,NR4A3,RDH16"	6
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Immune response of phagocytes	7.54E-03	"ITGB2,LY96,MUC1,SAA1,TNFRSF9,VTN"	6
Organismal Injury and Abnormalities	Fibrosis	7.66E-03	"ACE2,CTSS,EBI3,ERG,IL21R,LOR,LRRC15,MYH2,SH2D1B,SLC18A3,UBD,VTN"	12
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities,Reproductive System Disease"	Advanced ovarian adenocarcinoma	7.82E-03	"ABCA8,CACNA1A,DAB2,MUC1"	4
Post-Translational Modification	Cross-linkage of peptide	7.84E-03	"LOR,TGM1"	2
"Cardiovascular System Development and Function,Tissue Development"	Binding of endothelial tissue	7.84E-03	"OLR1,VTN"	2
"Cancer,Organismal Injury and Abnormalities"	Cancer of cells	8.09E-03	"ABCA4,ADAMTS14,ARHGDIG,ART5,ATP13A4,BIRC3,C1QTNF2,CACNA1A,DAAM1,DAB2,DNAJC12,EBI3,EMILIN2,ERG,FBLN5,FLG2,GBX1,GRPR,HHLA2,HOXD1,HSD17B6,IL21R,ITGB2,IZUMO4,JPH2,KCNK9,KLHL6,KRTAP2-3/KRTAP2-4,LCE1F,LOR,MUC1,MYH2,NR4A3,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RFTN1,RXRG,RYR3,SLCO5A1,SMPDL3B,STOML3,STX11,TEX14,TEX15,TMPRSS7,TNFAIP8L3,TNFRSF9,UBD,UBE2QL1,VTN"	54
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	T cell response	8.11E-03	"EBI3,IL21R,PDCD1LG2,PLP1,TNFRSF9"	5
"Neurological Disease,Organismal Injury and Abnormalities"	Primary tonic-clonic seizure	8.55E-03	"CA13,CACNA1A"	2
Cellular Movement	Haptotaxis of tumor cell lines	8.55E-03	"DAAM1,VTN"	2
"Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology"	Quantity of natural killer T lymphocytes	8.61E-03	"CTSS,EBI3,TNFRSF9"	3
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Activation of T lymphocytes	8.88E-03	"IL21R,ITGB2,NR4A3,PDCD1LG2,PLP1,SAA1,STX11,TNFRSF9"	8
Cell Death and Survival	Cytolysis	9.09E-03	"IL21R,ITGB2,MUC1,SH2D1B,STX11,TENT5C,ULBP2"	7
"Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology"	Quantity of T lymphocytes	9.28E-03	"CTSS,EBI3,FOSB,IL21R,ITGB2,MUC1,PDCD1LG2,PLP1,SAA1,TNFRSF9,VIPR2"	11
Cardiovascular Disease	Stage II hypertension	9.29E-03	"ACE2,CA13"	2
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Autosomal dominant early infantile epileptic encephalopathy	9.29E-03	"CACNA1A,KCNB1"	2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Response of Th2 cells	9.29E-03	"IL21R,PDCD1LG2"	2
"Cardiovascular System Development and Function,Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Organ Development,Organismal Development,Skeletal and Muscular System Development and Function,Tissue Development"	Generation of cardiomyocytes	9.29E-03	"DAAM1,JPH2"	2
Cell Cycle	G1 phase of prostate cancer cell lines	9.29E-03	"DAB2,ERG"	2
"Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Migration of phagocytes	9.46E-03	"ASB2,CTSS,IL21R,ITGB2,SAA1,TNFRSF9,VTN"	7
Cell Death and Survival	Apoptosis of neutrophils	9.67E-03	"ITGB2,TNFRSF9,VTN"	3
Cell-To-Cell Signaling and Interaction	Activation of cells	9.71E-03	"ABCA4,CACNA1A,CTSS,DAPP1,DDIT4,IL21R,ITGB2,LY96,NR4A3,PDCD1LG2,PLP1,SAA1,STX11,TNFRSF9,ULBP2,VIPR2,VTN"	17
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Aggregation of blood cells	9.91E-03	"DAB2,EMILIN2,ITGB2,OLR1,TNFRSF9,VTN"	6
Cellular Function and Maintenance	Function of antigen presenting cells	9.91E-03	"BIRC3,CTSS,IL21R,IL31RA,LY96,PDCD1LG2"	6
"Hereditary Disorder,Organismal Injury and Abnormalities,Renal and Urological Disease"	Hereditary renal tubular disorder	1.00E-02	"ATP6V0A4,CA13,MUC1"	3
Immunological Disease	Onset of autoimmune disease	1.01E-02	"PLP1,TNFRSF9"	2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Interaction of natural killer cells	1.01E-02	"SAA1,ULBP2"	2
"Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease"	Diabetic nephropathy	1.01E-02	"ACE2,ARHGDIG,AZGP1,CA13,FBP1,MOBP,OLR1,RDH16"	8
"Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities"	Diabetic complication	1.03E-02	"ACE2,ARHGDIG,AZGP1,CA13,CACNA1A,FBP1,MOBP,OLR1,RDH16"	9
Organismal Injury and Abnormalities	Hypertrophy	1.03E-02	"ACE2,ANKRD1,CYP2J2,ERG,HSPB2,IHH,JPH2,NR4A3,RXRG,SLC18A3"	10
"Cardiovascular System Development and Function,Organismal Development"	Formation of neointima	1.04E-02	"FBLN5,NR4A3,VTN"	3
"Dermatological Diseases and Conditions,Immunological Disease,Organismal Injury and Abnormalities"	Pemphigus foliaceus	1.04E-02	"HSPB2,IHH,ZBED2"	3
"Hematological System Development and Function,Humoral Immune Response,Lymphoid Tissue Structure and Development,Tissue Morphology"	Quantity of plasma cells	1.04E-02	"ITGB2,PDCD1LG2,RASGRP3"	3
"Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology"	Quantity of helper T lymphocytes	1.06E-02	"EBI3,IL21R,PLP1,SAA1"	4
Infectious Diseases	Infection by lymphocytic choriomeningitis virus	1.09E-02	"ITGB2,TNFRSF9"	2
"Dermatological Diseases and Conditions,Organ Morphology,Organismal Injury and Abnormalities"	Redness of skin	1.09E-02	"ITGB2,TGM1"	2
"Hematological Disease,Metabolic Disease,Organismal Injury and Abnormalities"	Hypokalemia	1.09E-02	"CA13,KCNK9"	2
"Ophthalmic Disease,Organismal Injury and Abnormalities"	Exfoliative glaucoma	1.09E-02	"CACNA1A,SAA1"	2
"Hematological System Development and Function,Hypersensitivity Response,Tissue Morphology"	Quantity of eosinophils	1.09E-02	"EBI3,IL21R,ITGB2,VIPR2"	4
Immunological Disease	Hypersensitive reaction	1.11E-02	"GPD1,HCP5,IL21R,IL31RA,ITGB2,LOR,PLP1,TNFRSF9,VIPR2"	9
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Prostate cancer	1.12E-02	"ABCA4,ADAMTS14,ANKRD1,ASB2,ATP13A4,C1QTNF2,CACNA1A,DDIT4,DHRS9,ERG,FBLN5,FLG2,GBX1,GFRA3,GRPR,HSD17B6,IZUMO4,JPH2,KCNB1,KCNK9,LY96,MUC1,MYH2,NR4A3,OLR1,OTOP1,PRR9,RASGRP3,RTP4,RXRG,RYR3,SCIN,SH2D1B,SLC18A3,SLC7A7,SLCO5A1,SYT17,TEX14,TGM1,TGM4,TMPRSS7,VIPR2,VTN,WSCD2,ZMYND15"	45
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Female genital tract adenocarcinoma	1.14E-02	"ABCA4,ABCA8,ACE2,ATP6V0A4,AZGP1,CACNA1A,CRABP1,CRTAC1,DAB2,DYDC1,ERG,FBLN5,FLG2,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,KCNB1,KCNK9,MAP6,MUC1,MYH2,NMNAT2,OTOP1,PLP1,RAET1G,RASGRP3,RYR3,SAA1,SIRPB2,SLC18A3,SMPDL3B,STOML3,SYTL2,TEX15,TGM1,TGM4,TNFAIP8L3,TNFRSF9,UBE2QL1,VSIG1,VWA5B1,WSCD2"	44
"Cancer,Organismal Injury and Abnormalities"	Head and neck tumor	1.14E-02	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS2,DNAJC12,DYDC2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,GBX1,GFRA3,GGTLC2,GPD1,GRPR,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,MAB21L4,MAP6,MOBP,MUC1,MYH2,NR4A3,OPN1SW,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RYR3,SCEL,SCIN,SH2D1B,SLCO5A1,SMPDL3B,SPINK2,STX11,SYT17,SYTL2,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBE2QL1,ULBP2,VIPR2,VTN,VWA5B1,WSCD2,ZMYND15"	98
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Breast or gynecological cancer	1.19E-02	"ABCA4,ABCA8,ACE2,ADAMTS14,ART5,ATP6V0A4,AZGP1,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DDIT4,DYDC1,EMILIN2,ERG,FBLN5,FLG2,FOSB,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,JPH2,KCNB1,KCNK9,KLHL6,KRT23,LRRC15,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RYR3,SAA1,SIRPB2,SLC18A3,SMPDL3B,SPINK2,STOML3,SYT17,SYTL2,TEX14,TEX15,TGM1,TGM4,TNFAIP8L3,TNFRSF9,TSPAN11,UBE2QL1,VSIG1,VTN,VWA5B1,WSCD2"	62
"Metabolic Disease,Organismal Injury and Abnormalities"	Glucose metabolism disorder	1.21E-02	"ACE2,ARHGDIG,ASB2,AZGP1,CA13,CACNA1A,CTSS,FBP1,GPD1,GPR1,HCP5,IL21R,ITGB2,MOBP,NR4A3,OLR1,OPN1SW,PDCD1LG2,RDH16,RTP4,RYR3,SH2D1B,TNFRSF9"	23
Cell Death and Survival	Apoptosis of septal cells	1.21E-02	DDIT4	1
"Cell Death and Survival,Cellular Development,Cellular Function and Maintenance"	Self-renewal of leukemia cell lines	1.21E-02	MUC1	1
"Cellular Movement,Embryonic Development"	Migration of embryonic stem cell lines	1.21E-02	RASGRP3	1
"Dermatological Diseases and Conditions,Hair and Skin Development and Function,Organ Morphology,Organismal Injury and Abnormalities"	Abnormal morphology of wavy vibrissae	1.21E-02	LIPH	1
"Cardiovascular Disease,Organismal Injury and Abnormalities"	Formation of embolus	1.21E-02	VTN	1
"Cellular Assembly and Organization,Cellular Development"	Differentiation of cell membrane leading edge	1.21E-02	DAB2	1
"Cardiovascular System Development and Function,Organismal Development,Tissue Morphology"	Vasodilation of afferent arteriole	1.21E-02	CYP2J2	1
"Cancer,Cellular Development,Organismal Injury and Abnormalities,Tumor Morphology"	Transdifferentiation of malignant tumor	1.21E-02	MUC1	1
"Cellular Assembly and Organization,Nervous System Development and Function"	Stabilization of myelin sheath	1.21E-02	PLP1	1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Organismal Injury and Abnormalities,Reproductive System Disease"	Spermatogenic failure 1	1.21E-02	TEX15	1
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Signaling of peripheral T lymphocyte	1.21E-02	ITGB2	1
"Cellular Assembly and Organization,Post-Translational Modification,Protein Degradation,Protein Synthesis"	Cleavage of actin	1.21E-02	SCIN	1
"Carbohydrate Metabolism,Drug Metabolism,Small Molecule Biochemistry"	Activation of heparin	1.21E-02	VTN	1
"DNA Replication, Recombination, and Repair,Nucleic Acid Metabolism,Small Molecule Biochemistry"	Hydrolysis of UTP	1.21E-02	ABCA4	1
"Cell Morphology,Hematological System Development and Function,Inflammatory Response"	Elongation of macrophages	1.21E-02	VTN	1
Cell Death and Survival	Killing of Staphylococcus aureus subsp. aureus str. Newman	1.21E-02	CTSS	1
"Lipid Metabolism,Small Molecule Biochemistry"	Conversion of diacylglycerol	1.21E-02	LIPH	1
"DNA Replication, Recombination, and Repair,Nucleic Acid Metabolism,Small Molecule Biochemistry"	Hydrolysis of CTP	1.21E-02	ABCA4	1
Cell Cycle	Arrest in Gap 0-Gap 1 phase of prostate cancer cell lines	1.21E-02	ERG	1
"Organismal Development,Skeletal and Muscular System Development and Function"	Thickness of footpad	1.21E-02	LOR	1
"Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking"	Immobilization of T lymphocytes	1.21E-02	ITGB2	1
"Digestive System Development and Function,Organ Morphology,Organismal Development"	Mass of colon	1.21E-02	TNFRSF9	1
"Cellular Assembly and Organization,Embryonic Development,Hair and Skin Development and Function,Organ Development,Organismal Development,Tissue Development"	Formation of cross-linked envelopes	1.21E-02	TGM1	1
"Embryonic Development,Nervous System Development and Function,Organ Development,Organismal Development,Tissue Development"	Development of vestibular nucleus	1.21E-02	CACNA1A	1
"Connective Tissue Disorders,Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities"	Autosomal dominant cutis laxa type 1	1.21E-02	FBLN5	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Oxidation of 13-cis-retinol	1.21E-02	RDH16	1
"Cell-To-Cell Signaling and Interaction,Nervous System Development and Function"	Activation of Purkinje cells	1.21E-02	CACNA1A	1
"Cellular Development,Connective Tissue Development and Function,Skeletal and Muscular System Development and Function,Tissue Development"	Onset of differentiation of chondrocytes	1.21E-02	IHH	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Spinocerebellar ataxia type 6	1.21E-02	CACNA1A	1
Neurological Disease	Head tremor	1.21E-02	PLP1	1
"Cell Morphology,Cellular Compromise"	Multinucleation of colorectal cancer cell lines	1.21E-02	UBD	1
"Cellular Growth and Proliferation,Skeletal and Muscular System Development and Function"	Inhibition of smooth muscle cells	1.21E-02	FBLN5	1
"Cancer,Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Angiogenesis of pancreatic endocrine tumor	1.21E-02	CTSS	1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Autosomal recessive childhood-onset severe retinal dystrophy	1.21E-02	ABCA4	1
"Hair and Skin Development and Function,Organ Morphology"	Yellowness of fur	1.21E-02	ACE2	1
"Gastrointestinal Disease,Hematological Disease,Hepatic System Disease,Organismal Injury and Abnormalities,Respiratory Disease"	Hypoxia of liver	1.21E-02	ITGB2	1
"Cell Morphology,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Cell spreading of bone marrow-derived dendritic cells	1.21E-02	ASB2	1
"Cellular Assembly and Organization,Cellular Compromise"	Disruption of microtubule cytoskeleton	1.21E-02	ERG	1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Mandibulofacial dysostosis with mental deficiency	1.21E-02	ABCA4	1
"Embryonic Development,Tissue Morphology"	Remodeling of yolk sac	1.21E-02	IHH	1
"Cell-To-Cell Signaling and Interaction,Nervous System Development and Function"	Action potential of spinal neuron	1.21E-02	GRPR	1
"Connective Tissue Disorders,Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities"	Autosomal recessive cutis laxa type 1A	1.21E-02	FBLN5	1
"Dermatological Diseases and Conditions,Immunological Disease,Organismal Injury and Abnormalities"	Anaphylaxis of skin	1.21E-02	VIPR2	1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Fundus flavimaculatus	1.21E-02	ABCA4	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Oxidation of vitamin A	1.21E-02	RDH16	1
"Cell Signaling,Molecular Transport,Nucleic Acid Metabolism,Small Molecule Biochemistry"	Guanine nucleotide exchange of guanosine 5'-O-(3-thiotriphosphate)	1.21E-02	GRPR	1
"Cardiovascular System Development and Function,Tissue Morphology"	Opening of carotid artery	1.21E-02	VTN	1
"Cell-mediated Immune Response,Hematopoiesis,Lymphoid Tissue Structure and Development"	Frequency of pro T4 thymocytes	1.21E-02	RASGRP3	1
Cardiovascular System Development and Function	Preservation of elastic lamina	1.21E-02	CTSS	1
"Cardiovascular Disease,Hematological Disease,Organismal Injury and Abnormalities"	Instability of thrombus	1.21E-02	VTN	1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities"	Hyperplasia of Th2 cells	1.21E-02	PLP1	1
"Energy Production,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Oxidation of 9-cis-retinol	1.21E-02	RDH16	1
"Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Humoral Immune Response,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development"	Formation of plasmablasts	1.21E-02	IL21R	1
"Cellular Assembly and Organization,Post-Translational Modification"	Bending of actin	1.21E-02	SCIN	1
"Cellular Movement,Hematological System Development and Function,Hypersensitivity Response,Immune Cell Trafficking"	Influx of eosinophils	1.21E-02	LY96	1
Cardiovascular System Development and Function	Extensibility of carotid artery	1.21E-02	FBLN5	1
"Cardiovascular Disease,Developmental Disorder,Organismal Injury and Abnormalities,Respiratory Disease"	Total anomalous pulmonary venous return	1.21E-02	ANKRD1	1
"Immunological Disease,Inflammatory Disease,Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities"	Initiation of experimental autoimmune encephalomyelitis	1.21E-02	PLP1	1
"Cancer,Cellular Growth and Proliferation,Organismal Functions,Organismal Injury and Abnormalities,Tumor Morphology"	Inhibition of non-small-cell lung cancer cells	1.21E-02	DDIT4	1
"Cancer,Cellular Growth and Proliferation,Organismal Injury and Abnormalities,Tumor Morphology"	Cytostasis of myeloid leukemia cells	1.21E-02	ASB2	1
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Invasion of growth plate	1.21E-02	IHH	1
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Immune response of monocyte-derived dendritic cells	1.21E-02	MUC1	1
Post-Translational Modification	Carbonyl modification of protein	1.21E-02	ABCA4	1
"Cellular Compromise,Cellular Function and Maintenance,Organismal Injury and Abnormalities"	Endoplasmic reticulum stress response of retinal cone cells	1.21E-02	OPN1SW	1
"Cardiovascular System Development and Function,Cell-To-Cell Signaling and Interaction"	Attachment of HCAEC cells	1.21E-02	ITGB2	1
"Cell Morphology,Hematological System Development and Function,Inflammatory Response,Nervous System Development and Function"	Area of microglia	1.21E-02	PLP1	1
"Cell Death and Survival,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Necrosis of epidermis	1.21E-02	ANKRD1	1
"Drug Metabolism,Protein Synthesis"	Metabolism of cyclosporin A	1.21E-02	CYP2J2	1
"Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking"	Arrest in cell rolling of memory T lymphocytes	1.21E-02	ITGB2	1
"Cell Death and Survival,Organismal Injury and Abnormalities"	Apoptosis of HCAEC cells	1.21E-02	OLR1	1
"Dermatological Diseases and Conditions,Hereditary Disorder,Organismal Injury and Abnormalities"	Hypotrichosis type 7	1.21E-02	LIPH	1
"Cell Morphology,Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Nervous System Development and Function,Skeletal and Muscular System Development and Function,Tissue Development,Tissue Morphology"	Size of motor endplates	1.21E-02	SLC18A3	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Sequestration of cholesterol	1.21E-02	PLP1	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Quantity of prostaglandin G2	1.21E-02	ABCA4	1
"Cancer,Cellular Development,Organismal Injury and Abnormalities,Tumor Morphology"	Differentiation of chronic myelogenous leukemia cells	1.21E-02	MUC1	1
Cellular Development	Delay in initiation of differentiation of leukemia cell lines	1.21E-02	ASB2	1
Skeletal and Muscular Disorders	Abnormality of foot	1.24E-02	"ITGB2,KRT83,VIPR2"	3
"Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development"	Proliferation of activated T lymphocytes	1.24E-02	"HHLA2,ITGB2,PDCD1LG2"	3
"Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development"	Clonal expansion of T lymphocytes	1.25E-02	"PLP1,TNFRSF9"	2
"Ophthalmic Disease,Organismal Injury and Abnormalities"	Open-angle glaucoma	1.29E-02	"CA13,CACNA1A,SAA1"	3
"Cellular Development,Cellular Growth and Proliferation"	Proliferation of blood cells	1.30E-02	"BIRC3,DAPP1,EBI3,ERG,HHLA2,IL21R,IL31RA,ITGB2,LY96,NR4A3,PDCD1LG2,PLP1,RASGRP3,TNFRSF9,ULBP2"	15
Tissue Development	Mineralization of extracellular matrix	1.34E-02	"IHH,VTN"	2
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Tumorigenesis of reproductive tract	1.37E-02	"ABCA4,ABCA8,ACE2,ATP6V0A4,AZGP1,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DYDC1,ERG,FBLN5,FLG2,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,JPH2,KCNB1,KCNK9,KRT23,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RXRG,RYR3,SAA1,SIRPB2,SLC18A3,SMPDL3B,STOML3,SYTL2,TEX15,TGM1,TGM4,TNFAIP8L3,TNFRSF9,UBE2QL1,VSIG1,VTN,VWA5B1,WSCD2"	52
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Female genital neoplasm	1.43E-02	"ABCA4,ABCA8,ACE2,ATP6V0A4,AZGP1,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DYDC1,ERG,FBLN5,FLG2,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,JPH2,KCNB1,KCNK9,KRT23,MAP6,MUC1,MYH2,NMNAT2,NR4A3,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RXRG,RYR3,SAA1,SIRPB2,SLC18A3,SMPDL3B,STOML3,SYTL2,TEX15,TGM1,TGM4,TNFAIP8L3,TNFRSF9,UBE2QL1,VSIG1,VTN,VWA5B1,WSCD2"	52
"Cellular Function and Maintenance,Hematological System Development and Function"	Function of CD8+ T lymphocyte	1.43E-02	"IL21R,PDCD1LG2"	2
"Cell-To-Cell Signaling and Interaction,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response"	Phagocytosis by peritoneal macrophages	1.43E-02	"SAA1,VTN"	2
"Connective Tissue Disorders,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Rheumatic Disease	1.51E-02	"ADAMTS14,AZGP1,CACNA1A,CTSS,EBI3,ERG,FOSB,HSPB2,IHH,IL21R,ITGB2,NMNAT2,NR4A3,PDCD1LG2,RASGRP3,SAA1,TNFRSF9,VIPR2,VTN,ZBED2"	20
"Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization,Hematological System Development and Function,Immune Cell Trafficking"	Cell-cell adhesion of leukocytes	1.52E-02	"ITGB2,OLR1"	2
"Cardiovascular Disease,Organismal Injury and Abnormalities"	Vaso-occlusion	1.58E-02	"BIRC3,CA13,CTSS,ERG,FOSB,ITGB2,OLR1,SAA1,TNFRSF9,VTN"	10
Cell Death and Survival	Apoptosis of phagocytes	1.58E-02	"BIRC3,ITGB2,NR4A3,TNFRSF9,VTN"	5
"Cell Morphology,Embryonic Development,Hair and Skin Development and Function,Organ Development,Organismal Development,Tissue Development"	Keratinization of epidermis	1.59E-02	"KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1"	4
"Humoral Immune Response,Protein Synthesis"	Quantity of IgA	1.61E-02	"IL21R,ITGB2,TNFRSF9"	3
Organismal Functions	Basal metabolic rate	1.62E-02	"RXRG,UBD"	2
"Cellular Development,Cellular Growth and Proliferation,Reproductive System Development and Function"	Proliferation of prostate cell lines	1.62E-02	"DAB2,ERG"	2
"Inflammatory Response,Organismal Injury and Abnormalities"	Inflammation of organ	1.62E-02	"ABCA4,ACE2,ASB2,BIRC3,CA13,CTSS,DDIT4,EBI3,GPD1,IL21R,IL31RA,ITGB2,LOR,LY96,MUC1,PDCD1LG2,PLP1,RFTN1,RXRG,TNFRSF9,UBD"	21
Molecular Transport	Transport of molecule	1.63E-02	"ABCA4,ANKRD1,ATP13A4,ATP6V0A4,C1QTNF2,CA13,CACNA1A,CTSS,FBLN5,FOSB,KCNB1,KCNG3,KCNK9,NR4A3,OLR1,OTOP1,RYR3,SAA1,SLC18A3,SLC7A7,STOML3,STX11,SYTL2,TNFAIP8L3"	24
"Cell-To-Cell Signaling and Interaction,Inflammatory Response"	Immune response of T lymphocytes	1.63E-02	"PDCD1LG2,PLP1,TNFRSF9,VTN"	4
"Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development"	Proliferation of lymphocytes	1.64E-02	"BIRC3,DAPP1,EBI3,HHLA2,IL21R,IL31RA,ITGB2,LY96,PDCD1LG2,PLP1,RASGRP3,TNFRSF9,ULBP2"	13
"Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development"	Development of helper T lymphocytes	1.66E-02	"IL21R,ITGB2,TNFRSF9"	3
"Humoral Immune Response,Protein Synthesis"	Quantity of IgG3	1.66E-02	"DAPP1,IL21R,TNFRSF9"	3
"Organismal Injury and Abnormalities,Respiratory Disease"	Chronic obstructive pulmonary disease	1.66E-02	"CA13,CTSS,DDIT4,FBLN5,KCNK9"	5
Cell-To-Cell Signaling and Interaction	Adhesion of tumor cell lines	1.69E-02	"CYP2J2,DAB2,FBLN5,ITGB2,MUC1,SAA1,VTN"	7
Nutritional Disease	Central obesity	1.71E-02	"ACE2,CA13"	2
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Metabolism of retinol	1.71E-02	"DHRS9,RDH16"	2
"Cardiovascular System Development and Function,Cell-To-Cell Signaling and Interaction"	Binding of endothelial cells	1.74E-02	"ERG,FBLN5,ITGB2,OLR1,VTN"	5
Cell-To-Cell Signaling and Interaction	Aggregation of cells	1.80E-02	"DAB2,EMILIN2,ITGB2,MUC1,OLR1,TNFRSF9,VTN"	7
"Cell Morphology,Cellular Movement"	Cell spreading of lung cell lines	1.81E-02	VTN	1
"Dermatological Diseases and Conditions,Hereditary Disorder,Organismal Injury and Abnormalities"	Autosomal recessive congenital ichthyosis type 1	1.81E-02	TGM1	1
"Cardiovascular System Development and Function,Connective Tissue Development and Function,Tissue Morphology"	Thickness of vessel tunica externa	1.81E-02	FBLN5	1
"Cellular Function and Maintenance,Tissue Development"	Organization of cell envelopes	1.81E-02	TGM1	1
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Conjugation of B-lymphocyte derived cell lines	1.81E-02	ITGB2	1
"Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization"	Cell-cell adhesion of leukemia cell lines	1.81E-02	DAB2	1
"DNA Replication, Recombination, and Repair"	Injury of DNA	1.81E-02	CTSS	1
Cellular Development	Differentiation of neuronal hybrid cells	1.81E-02	NR4A3	1
Cell Cycle	Arrest in cell cycle progression of neuronal hybrid cells	1.81E-02	NR4A3	1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Brachydactyly type A1	1.81E-02	IHH	1
"Cellular Assembly and Organization,Cellular Compromise"	Formation of polyglutamine inclusion	1.81E-02	HSPB2	1
"Cancer,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Squamous papilloma	1.81E-02	IHH	1
"Cellular Assembly and Organization,Nervous System Development and Function"	Turnover of synaptic vesicles	1.81E-02	CACNA1A	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Clearance of retinaldehyde	1.81E-02	ABCA4	1
Infectious Diseases	Infectivity of Rhesus rotavirus	1.81E-02	VTN	1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Susceptibility to migraine type 1	1.81E-02	CACNA1A	1
Behavior	Falling of mice	1.81E-02	RXRG	1
"Cellular Assembly and Organization,Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Organ Development,Organismal Development,Reproductive System Development and Function,Tissue Development"	Formation of zona pellucida	1.81E-02	IHH	1
"Cell Morphology,Organ Morphology,Organismal Development,Renal and Urological System Development and Function,Tissue Morphology"	Thickness of glomerular basement membrane	1.81E-02	ACE2	1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Autosomal dominant monilethrix	1.81E-02	KRT83	1
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Synthesis of retinaldehyde	1.81E-02	ABCA4	1
"Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Trafficking of neutrophils	1.81E-02	ITGB2	1
Organismal Injury and Abnormalities	Obstruction of lumen	1.81E-02	OLR1	1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Bull's eye maculopathy	1.81E-02	ABCA4	1
"Drug Metabolism,Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Quantity of alitretinoin	1.81E-02	RDH16	1
"Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities"	Leukocyte adhesion deficiency type I	1.81E-02	ITGB2	1
"Nervous System Development and Function,Neurological Disease"	Lack of superior cervical ganglion	1.81E-02	GFRA3	1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Achondroplastic dwarfism	1.81E-02	IHH	1
"Lipid Metabolism,Small Molecule Biochemistry"	"Synthesis of 11,12-epoxyeicosatrienoic acid"	1.81E-02	OLR1	1
Cell Cycle	Polyploidization of leukemia cell lines	1.81E-02	SCIN	1
"DNA Replication, Recombination, and Repair,Nucleic Acid Metabolism,Small Molecule Biochemistry"	Hydrolysis of NAD+	1.81E-02	ART5	1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities"	Stargardt disease 1	1.81E-02	ABCA4	1
Cellular Function and Maintenance	Internalization of Yersinia pestis	1.81E-02	LY96	1
"Cellular Function and Maintenance,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Retention of monocytes	1.81E-02	ITGB2	1
"Cancer,Cell Death and Survival,Organismal Injury and Abnormalities,Tumor Morphology"	Lysis of myeloma cells	1.81E-02	ULBP2	1
"Metabolic Disease,Organismal Injury and Abnormalities"	AA amyloidosis	1.81E-02	SAA1	1
"Cell Morphology,Hematological System Development and Function,Inflammatory Response"	Cell flattening of macrophages	1.81E-02	VTN	1
"Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease"	Autosomal recessive distal renal tubular acidosis	1.81E-02	ATP6V0A4	1
Cell-To-Cell Signaling and Interaction	Density of focal adhesions	1.81E-02	VTN	1
"Cell-To-Cell Signaling and Interaction,Molecular Transport,Small Molecule Biochemistry"	Transport of acetylcholine	1.81E-02	SLC18A3	1
"Cellular Development,Embryonic Development,Organismal Development,Tissue Development"	Differentiation of visceral endoderm	1.81E-02	DAB2	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry,Vitamin and Mineral Metabolism"	Quantity of retinyl palmitate	1.81E-02	ABCA4	1
"Drug Metabolism,Endocrine System Development and Function,Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Accumulation of beta-estradiol	1.81E-02	SAA1	1
"Cell Death and Survival,Organismal Injury and Abnormalities,Renal and Urological Disease"	Quantity of apoptotic kidney cell lines	1.81E-02	OLR1	1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities"	Erythrokeratodermia variabilis et progressiva 1	1.81E-02	GJB4	1
"Neurological Disease,Organ Morphology,Organismal Injury and Abnormalities"	Atrophy of cerebellar cortex	1.81E-02	CACNA1A	1
Behavior	Reversal learning	1.81E-02	SLC18A3	1
Cellular Compromise	Degeneration of nucleus	1.81E-02	TGM1	1
Nervous System Development and Function	Spreading depression of hippocampus	1.81E-02	CACNA1A	1
"Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry"	Absorption of triolein	1.81E-02	AZGP1	1
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities"	Refractory skin manifestation	1.81E-02	RXRG	1
"Cell Cycle,Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Inflammatory Response"	Effector phase of CD8+ T lymphocyte	1.81E-02	TNFRSF9	1
Visual System Development and Function	Light sensitivity of photoreceptors	1.81E-02	ABCA4	1
"Cell-mediated Immune Response,Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking"	Cell-cell adhesion of T lymphocytes	1.81E-02	ITGB2	1
"Embryonic Development,Nervous System Development and Function,Organ Development,Organismal Development"	Maturation of cerebellum	1.81E-02	CACNA1A	1
"Cell Morphology,Cellular Movement,Nervous System Development and Function"	Innervation of sympathetic neuron	1.81E-02	GFRA3	1
"Cancer,Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities"	Angiogenesis of pancreatic carcinoma	1.81E-02	CTSS	1
"Cell-To-Cell Signaling and Interaction,Cellular Compromise,Tumor Morphology"	Adhesion of glioma cells	1.81E-02	VTN	1
"Immune Cell Trafficking,Inflammatory Response"	Margination of neutrophils	1.81E-02	ITGB2	1
"Cardiovascular Disease,Cardiovascular System Development and Function,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders"	Nonischemic dilated cardiomyopathy	1.81E-02	SLC18A3	1
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Lymphoid Tissue Structure and Development"	Clustering of follicular dendritic cells	1.81E-02	TNFRSF9	1
"Cellular Development,Cellular Growth and Proliferation,Tissue Development"	Proliferation of epithelial stem cells	1.81E-02	IHH	1
Cellular Assembly and Organization	Transport of lysosome	1.81E-02	MAP6	1
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function"	Interaction of invariant natural killer T cells	1.81E-02	SAA1	1
"Cellular Assembly and Organization,Tissue Morphology"	Quantity of melanosomes	1.81E-02	SYTL2	1
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Humoral Immune Response,Immune Cell Trafficking,Inflammatory Response"	Hyperactivation of B lymphocytes	1.81E-02	ITGB2	1
Cell Death and Survival	Killing of leukemia cell lines	1.81E-02	"RAET1L,ULBP2"	2
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease"	Female genital tract cancer	1.85E-02	"ABCA4,ABCA8,ACE2,ATP6V0A4,AZGP1,CACNA1A,CRABP1,CRTAC1,CTSS,DAB2,DYDC1,ERG,FBLN5,FLG2,GRPR,HHLA2,HSD17B6,IL21R,IL31RA,JPH2,KCNB1,KCNK9,KRT23,MAP6,MUC1,MYH2,NMNAT2,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RYR3,SAA1,SIRPB2,SLC18A3,SMPDL3B,STOML3,SYTL2,TEX15,TGM1,TGM4,TNFAIP8L3,TNFRSF9,UBE2QL1,VSIG1,VTN,VWA5B1,WSCD2"	50
"Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking"	Transmigration of mononuclear leukocytes	1.87E-02	"CTSS,ITGB2,PDCD1LG2"	3
"Cancer,Organismal Injury and Abnormalities"	Head and neck cancer	1.87E-02	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CYP2J2,DAAM1,DAB2,DAPP1,DHRS2,DNAJC12,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,FLG2,GBX1,GFRA3,GGTLC2,GPD1,GRPR,HOXD1,HSD17B6,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,MAB21L4,MAP6,MOBP,MUC1,MYH2,NR4A3,OPN1SW,OTOP1,PDCD1LG2,PLP1,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RYR3,SCEL,SCIN,SH2D1B,SLCO5A1,SMPDL3B,SPINK2,STX11,SYT17,SYTL2,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TP53I3,TSPAN11,UBE2QL1,ULBP2,VIPR2,VTN,VWA5B1,WSCD2,ZMYND15"	96
Cellular Compromise	Stress response of cells	1.88E-02	"CTSS,HSPB2,MUC1,OPN1SW"	4
"Cancer,Organismal Injury and Abnormalities,Renal and Urological Disease"	Bladder carcinoma	1.88E-02	"ADAMTS14,CACNA1A,DHRS9,EMILIN2,FBLN5,FOSB,ITGB2,MAP6,OTOP1,PIFO,RYR3,STX11,SYTL2,TEX15,TMPRSS7,TNFAIP8L3,VIPR2"	17
Cell Death and Survival	Cytolysis by cytotoxic T cells	1.92E-02	"IL21R,STX11"	2
Molecular Transport	Transmembrane transport of H+	1.92E-02	"ATP6V0A4,OTOP1"	2
"Cellular Development,Cellular Growth and Proliferation,Nervous System Development and Function"	Proliferation of oligodendrocyte precursor cells	1.92E-02	"PLP1,VTN"	2
"Cell-To-Cell Signaling and Interaction,Cellular Compromise,Cellular Function and Maintenance,Hematological System Development and Function,Inflammatory Response"	Respiratory burst of neutrophils	1.92E-02	"ITGB2,VTN"	2
"Cancer,Organismal Injury and Abnormalities,Renal and Urological Disease"	Bladder cancer	1.99E-02	"ADAMTS14,BIRC3,CACNA1A,DHRS9,EMILIN2,FBLN5,FOSB,ITGB2,MAP6,OTOP1,PIFO,RYR3,STX11,SYTL2,TEX15,TMPRSS7,TNFAIP8L3,VIPR2"	18
Cell-To-Cell Signaling and Interaction	Binding of cell surface	2.02E-02	"LY96,VTN"	2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response"	Aggregation of phagocytes	2.02E-02	"ITGB2,TNFRSF9"	2
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities"	T(15;17) mutation negative acute myeloid leukemia	2.02E-02	"ERG,RXRG"	2
"Cellular Movement,Embryonic Development"	Migration of embryonic cell lines	2.03E-02	"ITGB2,RASGRP3,SAA1,VTN"	4
"Antimicrobial Response,Inflammatory Response"	Antiviral response	2.03E-02	"BIRC3,DDIT4,PLP1,RTP4,TNFRSF9"	5
"Cancer,Hematological Disease,Organismal Injury and Abnormalities"	Mature lymphocytic neoplasm	2.05E-02	"BIRC3,CACNA1A,EBI3,FLG2,IL21R,IL31RA,ITGB2,JPH2,KLHL6,MUC1,MYH2,NR4A3,PDCD1LG2,RFTN1,RXRG,RYR3,STX11,TENT5C,TEX14,TEX15,TNFRSF9,VTN"	22
Molecular Transport	Transport of monovalent inorganic cation	2.06E-02	"ATP6V0A4,KCNB1,KCNG3,KCNK9,OTOP1"	5
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities"	Nonpituitary endocrine tumor	2.08E-02	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CTSS,CYP2J2,DAAM1,DAPP1,DHRS2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,GBX1,GFRA3,GGTLC2,GPD1,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,MAB21L4,MAP6,MOBP,MUC1,MYH2,NR4A3,OPN1SW,OTOP1,PDCD1LG2,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RYR3,SCEL,SCIN,SH2D1B,SLCO5A1,SMPDL3B,SPINK2,STX11,SYT17,SYTL2,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBE2QL1,ULBP2,VIPR2,VTN,VWA5B1,WSCD2,ZMYND15"	92
"Humoral Immune Response,Protein Synthesis"	Quantity of IgE	2.09E-02	"IL21R,IL31RA,VIPR2"	3
"Inflammatory Disease,Organismal Injury and Abnormalities,Respiratory Disease"	Pulmonary emphysema	2.09E-02	"CTSS,DDIT4,FBLN5"	3
"Cell-To-Cell Signaling and Interaction,Cellular Growth and Proliferation,Hematological System Development and Function"	Stimulation of lymphocytes	2.11E-02	"HHLA2,MUC1,PDCD1LG2,TNFRSF9"	4
"Cancer,Organismal Injury and Abnormalities"	Benign Tumors	2.12E-02	"ABCA4,ABCA8,ASB2,GRPR,IHH,MUC1,MYH2,NR4A3,PDCD1LG2,PLP1,RXRG,SLC18A3,TNFRSF9,VTN"	14
"Connective Tissue Development and Function,Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders,Skeletal and Muscular System Development and Function,Tissue Development,Tissue Morphology"	Loss of bone	2.13E-02	"IHH,SCIN"	2
"Neurological Disease,Organismal Injury and Abnormalities"	Tonic-clonic seizure	2.19E-02	"CA13,CACNA1A,FOSB,KCNB1"	4
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities"	Autosomal dominant cerebellar ataxia	2.20E-02	"CACNA1A,MUC1,OPN1SW"	3
"Developmental Disorder,Endocrine System Disorders,Organismal Injury and Abnormalities,Reproductive System Disease"	Oligosynaptic infertility	2.24E-02	"TEX15,ZMYND15"	2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Humoral Immune Response"	Response of B lymphocytes	2.24E-02	"CTSS,DAPP1"	2
"Cancer,Organismal Injury and Abnormalities"	Growth of carcinoma	2.27E-02	"CTSS,FBLN5,MUC1,TNFRSF9"	4
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities"	Thyroid gland tumor	2.34E-02	"ABCA4,ABCA8,ACE2,ADAMTS14,ANKRD1,ARHGDIG,ART5,ASB2,ATP13A4,ATP6V0A4,AZGP1,BIRC3,C11orf96,C1QTNF2,CACNA1A,CRABP1,CRTAC1,CYP2J2,DAAM1,DAPP1,DHRS2,EBI3,EMILIN2,ERG,FAM133A,FBLN5,FBP1,GBX1,GFRA3,GGTLC2,GPD1,HOXD1,IHH,IL21R,IL31RA,ISM2,ITGB2,IZUMO4,JPH2,KCNB1,KCNG3,KLHL6,KRT23,KRT83,KRTAP2-3/KRTAP2-4,KRTAP3-1,LCE1E,LCE1F,LIPH,LOR,MAB21L4,MAP6,MOBP,MUC1,MYH2,NR4A3,OPN1SW,OTOP1,PDCD1LG2,RAET1G,RAET1L,RASGRP3,RASL10A,RDH16,RFTN1,RFX8,RYR3,SCEL,SCIN,SH2D1B,SLCO5A1,SMPDL3B,SPINK2,STX11,SYT17,SYTL2,TEX14,TEX15,TGM4,TMPRSS7,TNFAIP8L3,TNFRSF9,TP53I3,TSPAN11,UBE2QL1,ULBP2,VIPR2,VTN,VWA5B1,WSCD2,ZMYND15"	91
Cellular Assembly and Organization	Docking of vesicles	2.35E-02	"KCNB1,SYTL2"	2
